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Abstract
While research on the actions of ethanol at the GABAergic synapse has focused on postsynaptic
mechanisms, recent data have demonstrated that ethanol also facilitates GABA release from
presynaptic terminals in many, but not all, brain regions. The ability of ethanol to increase GABA
release can be regulated by different G protein-coupled receptors (GPCRs), such as the
cannabinoid-1 receptor, corticotropin-releasing factor 1 receptor, GABAB receptor, and the 5-
hydroxytryptamine 2C receptor. The intracellular messengers linked to these GPCRs, including
the calcium that is released from internal stores, also play a role in ethanol-enhanced GABA
release. Hypotheses are proposed to explain how ethanol interacts with the GPCR pathways to
increase GABA release and how this interaction contributes to the brain region specificity of
ethanol-enhanced GABA release. Defining the mechanism of ethanol-facilitated GABA release
will further our understanding of the GABAergic profile of ethanol and increase our knowledge of
how GABAergic neurotransmission may contribute to the intoxicating effects of alcohol and to
alcohol dependence.
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1. Introduction
While previously thought to be just an amino acid, gamma-aminobutyric acid (GABA) was
recognized as a major inhibitory neurotransmitter in the central nervous system during the
1960s (Krnjevic and Phillis, 1963; Otsuka et al., 1966; Roberts and Kuriyama, 1968). In the
presynaptic terminal, glutamate decar-boxylase converts glutamate into GABA, and GABA
is actively transported into the synaptic vesicles by a vacuolar proton pump that establishes
an electrochemical gradient across the vesicle (Martin, 1993; McIntire et al., 1997; Sagne et
al., 1997). The vesicles dock at the plasma membrane through an interaction between
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synaptobrevin, which is located on the synaptic vesicles, and syntaxin 1 and SNAP-25,
which are located on the plasma membrane (see Sudhof, 1995, 2004). This core complex
allows for a number of protein–protein interactions to occur that are necessary for
exocytosis, including the calcium sensor synaptotagmin triggering the final stage of vesicle
fusion with the membrane. Once the vesicles fuse with the membrane, GABA is released
from the presynaptic terminal into the synaptic cleft and binds to the postsynaptic GABAA
receptors, allowing chloride to flow into the neuron.
The flow of chloride through the GABAA receptor can be measured in an in vitro slice
preparation using whole-cell voltage-clamp recordings. This technique can measure both
spontaneous (action potential-independent and dependent) and evoked GABA release.
Action potential-independent GABA release is isolated by tetrodotoxin—a drug that blocks
action potentials via inhibition of voltage-gated sodium channels. Treatment with
tetrodotoxin allows for measurement of a GABAA receptor-mediated chloride flux response
known as a miniature inhibitory postsynaptic current (mIPSC). When the number of mIPSC
events is increased, the change is interpreted as an increase in spontaneous GABA release.
In the absence of tetrodotoxin, there is a mix of action potential-dependent and independent
GABA release, and this measured GABAA receptor-mediated chloride flux response is
referred to as a spontaneous inhibitory postsynaptic current (sIPSC). Interpreting an increase
in sIPSC frequency is not as straightforward as interpreting an increase in mIPSC frequency
because an increase in sIPSC frequency can be due to a direct effect on the presynaptic
terminal (i.e., increase in terminal release probability), an increase in action potential firing,
or activation of a neighboring neuron that affects the presynaptic neuron (i.e., increase in
somatic/axonal excitability).
In contrast to spontaneous GABA release, measuring evoked GABA release involves
stimulating an action potential to induce GABA release. This measured GABAA receptor-
mediated chloride flux response is known as an evoked inhibitory postsynaptic current
(eIPSC). Because there is no direct readout for changes in presynaptic release with analysis
of eIPSCs, a paired pulse ratio (PPR) is used to make this assessment. The PPR is the ratio
of the amplitudes of two eIPSCs (eIPSC2/eIPSC1) that are evoked by stimuli applied 20–200
ms apart (for review see Zucker, 1989). A change in the PPR is inversely related to a change
in evoked neurotransmitter release (Siggins et al., 2005); therefore, if ethanol decreases the
PPR, it is interpreted as ethanol increasing evoked GABA release. Through the use of
whole-cell voltage-clamp recordings and the analysis of mISPCs, sIPSCs, and eIPSCs, it
was determined that ethanol increases GABA release in the brain slice preparation, which
will be discussed in greater detail below.
2. The history of ethanol-enhanced GABA release
Starting in the late 1970s, there were a number of behavioral studies showing an interaction
between ethanol and drugs that affect the GABAA receptor (for reviews see Criswell and
Breese, 2005; Siggins et al., 2005; Weiner and Valenzuela, 2006), which led the field to
focus on ethanol–GABA interactions. One of the earliest studies on the effect of ethanol on
GABA function interpreted an overall decrease in brain GABA content following a 4.3 g/kg
ethanol dose as an indication that ethanol releases GABA from neurons (Gordon, 1967).
However, several subsequent studies failed to reproduce this effect (Frye and Breese, 1982;
Sutton and Simmonds, 1973; Volicer and Klosowicz, 1979). With the development of the
dialysis probe, additional studies produced varied but primarily negative results.
Systemically administering ethanol did not change GABA dialysate levels in the anterior
cingulate cortex (Zuo et al., 2007), hippocampus (Dahchour and De Witte, 1999; Ward et
al., 2009), ventral tegmental area (VTA; Kemppainen et al., 2010), or nucleus accumbens
(Smith et al., 2004). Systemic ethanol administration decreases GABA dialysate levels in the
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cerebellar nuclei (Manto et al., 2005) and ventral pallidum (Kemppainen et al., 2010). There
was also an ethanol-induced decrease in GABA dialysate in the nucleus accumbens in
alcohol-tolerant, but not alcohol-nontolerant, rat lines (Piepponen et al., 2002) and in
alcohol-dependent rats (Dahchour and De Witte, 2000). Thus, the preponderance of dialysis
data indicated a lack of ethanol effect on GABA release, or even a slight decrease, following
systemic ethanol administration.
When intracellular recordings were first used to study the GABAergic effect of ethanol,
Carlen et al. (1982) found that ethanol enhanced the size of eIPSCs recorded from the CA1
region of the hippocampus. While analyzing eIPSC size does not indicate whether ethanol is
acting pre- or postsynaptically (see Introduction), Carlen et al. (1982) nonetheless postulated
that the increase in eIPSC size was due to a presynaptic mechanism. Based upon a later
discovery that inhibition of GABAB receptors is necessary for ethanol to consistently
increase eIPSC amplitude in the hippocampus (Wan et al., 1996), the authors speculated that
these GABAB receptors were located presynaptically (Siggins et al., 1999). An experiment
with spinal cord neurons found that ethanol increases sIPSC frequency without having an
effect on sIPSC amplitude (Cheng et al., 1999). Together, these data provided the first clues
that ethanol might act at the presynaptic terminal to increase the release of GABA.
In 2002 Dr. Dennis Twombly organized a National Institute on Alcohol Abuse and
Alcoholism workshop to discuss the deficiency in studies exploring the presynaptic effects
of ethanol (see Roberto et al., 2006). By determining if ethanol had an effect on mIPSC
frequency and the PPR, a number of reports thereafter provided support for ethanol
increasing spontaneous and evoked GABA release, respectively, in a number of brain
regions (see Table 1 for summary). One of the first studies showed that ethanol increases
both spontaneous and evoked GABA release in the central nucleus of the amygdala (CeA;
Roberto et al., 2003). In addition to the CeA (Nie et al., 2004; Roberto et al., 2003), ethanol
has been shown to increase GABA release in the following brain regions: basolateral
amygdala (Silberman et al., 2008; Zhu and Lovinger, 2006), hippocampus (Ariwodola and
Weiner, 2004; Li et al., 2006; Sanna et al., 2004), VTA (Melis et al., 2002; Theile et al.,
2008), cerebellum (Carta et al., 2004; Criswell et al., 2008; Hirono et al., 2009; Kelm et al.,
2007; Kelm et al., 2008; Ming et al., 2006), substantia nigra (Criswell et al., 2008) and
brainstem/spinal cord (Sebe et al., 2003; Ziskind-Conhaim et al., 2003). Fig. 1 includes data
collected from the cerebellar interneuron-Purkinje cell synapse demonstrating that ethanol
increases mIPSC frequency (Fig. 1A and B) by increasing vesicular release of GABA (Fig.
1C) while having little or no effect postsynaptically (Fig. 1D). While ethanol has been
shown to increase GABA release in a number of brain regions with the use of slice
electrophysiology, ethanol does not increase GABA release in every brain region;
specifically, ethanol has no effect on GABA release in the cortex, lateral septum, and
thalamus (Criswell et al., 2008; Jia et al., 2008). In the brain regions where ethanol does
increase GABA release, significant progress has been made regarding the underlying
mechanism responsible for this action of ethanol.
The dichotomy between the effects of locally applied ethanol, which usually increases
GABA release when measured with intracellular recordings, and systemic ethanol, which
usually has no effect on GABA release when measured with dialysis, suggests that the net
effect of ethanol on intact neural circuits may differ from the effect of ethanol on individual
neurons. This difference may be due to ethanol increasing GABA release onto inhibitory
interneurons and thereby decreasing the subsequent release of GABA from the interneurons
(see Celada et al., 1999; Tan et al., 2010). Thus, local application of ethanol may be
necessary to study the immediate mechanism of ethanol-enhanced GABA release while the
indirect effect of ethanol on GABA function may be modeled with dialysis experiments.
Interestingly, when ethanol was applied locally by dialysis into the CeA, ethanol increased
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GABA release, which verified the effect of bath-applied ethanol on CeA neurons in the slice
preparation (Roberto et al., 2004, 2010).
3. G protein-coupled receptors influence ethanol-enhanced GABA release
A number of laboratories have demonstrated that the ability of ethanol to increase GABA
release can be regulated by different G protein-coupled receptors (GPCRs, see Table 2 for
summary). For example, the functionality of a Gαs- or Gαq-coupled GPCR is necessary for
ethanol to increase GABA release in certain brain regions. Inhibition of the corticotropin-
releasing factor (CRF)1 receptor, a GPCR coupled to Gαs, blocks ethanol from increasing
GABA release in the CeA (Nie et al., 2004;Roberto et al., 2010). This finding suggests that
activation of the CRF1 receptor is essential for ethanol to increase the release of GABA in
this brain region. Inhibition of the Gαq-coupled 5-hydroxytryptamine-2C (5-HT2C) receptor
blocks ethanol-enhanced GABA release in the VTA, which suggests that activation of the 5-
HT2C receptor is essential for ethanol to increase GABA release at this site (Theile et al.,
2009). More studies should be conducted to determine if activation of Gαs- or Gαq-coupled
GPCRs is necessary for ethanol to induce GABA release in different brain regions.
Agonists for Gαi-coupled GPCRs have the same inhibitory effect on ethanol-enhanced
GABA release as antagonists for the Gαs/Gαq-coupled GPCRs. In the basolateral amygdala,
activation of the Gαi-coupled cannabinoid-1 (CB1) receptor (Talani and Lovinger, 2008) or
activation of the Gαi-linked GABAB receptor (Silberman et al., 2009; Zhu and Lovinger,
2006) inhibits ethanol-enhanced GABA release. At the cerebellar interneuron-Purkinje cell
synapse, the ability of ethanol to increase GABA release is likewise blocked by activation of
CB1 receptors or GABAB receptors (Kelm et al., 2007, 2008). In the CeA, activation of
either the nociceptin/orphanin FQ peptide receptor (Roberto and Siggins, 2006), a Gαi-
coupled GPCR, or the CB1 receptor (Roberto et al., 2008) blocks ethanol from enhancing
GABA release. Consistent with activation of Gαi-coupled GPCRs inhibiting ethanol-
enhanced GABA release, inhibition of Gαi-coupled GPCRs enhances the ability of ethanol
to increase GABA release. In the basolateral amygdala (Ariwodola and Weiner, 2004;
Silberman et al., 2009) and hippocampus (Zhu and Lovinger, 2006), an antagonist for Gαi-
linked GABAB receptors enhances the ability of ethanol to increase GABA release, as does
an antagonist for the Gαi-linked CB1 receptors in the basolateral amygdala (Talani and
Lovinger, 2008). In the CeA, an antagonist at the Gαi-linked δ-opioid receptor augments the
ability of ethanol to increase the release of GABA (Kang-Park et al., 2007).
Interestingly, the presence of a Gαi-coupled GPCR does not guarantee that activation or
inhibition of the receptor will affect ethanol-enhanced GABA release. Both μ-opioid
receptor null mice and a μ-opioid receptor antagonist increase baseline GABA release in the
CeA but have no effect on the ability of ethanol to increase GABA release in the CeA
(Kang-Park et al., 2009). A GABAB receptor antagonist increases baseline GABA release in
the cerebellum, but inhibition of GABAB receptors does not affect ethanol-enhanced GABA
release in this brain region (Kelm et al., 2008). In the VTA neither a GABAB receptor
agonist nor antagonist had an effect on the ability of ethanol to increase GABA release,
despite the fact that both the agonist and antagonist affected baseline release of GABA
(Theile et al., 2008). Given that agonists and antagonists for the GPCRs mentioned above
affect baseline spontaneous GABA release, it is likely that these GPCRs are expressed at the
presynaptic terminals. Because the presence of a functional GPCR at a presynaptic terminal
does not guarantee that an agonist/antagonist for that GPCR will affect ethanol-enhanced
GABA release, it is unlikely that ethanol acts directly on a GPCR to regulate release of
GABA.
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Instead of binding directly to a GPCR to influence GABA release, ethanol could act
upstream of the GPCR to change the amount of ligand reaching the GPCR, or ethanol could
indirectly alter the affinity of the GPCR for its ligand or the constitutive activity of the
GPCR. The appropriate endogenous ligands are present in the CeA and the VTA, which are
sites where activation of the CRF1 receptor (Nie et al., 2004) and 5-HT2C receptor (Theile et
al., 2009), respectively, is required for ethanol-enhanced GABA release. Specifically,
GABAergic interneurons synthesize CRF in the CeA (Veinante et al., 1997), and
serotonergic afferents innervate neurons in the VTA (Herve et al., 1987). However, ethanol
could also act downstream from a GPCR to increase GABA release by binding to adenylate
cyclase (Yoshimura et al., 2006) or protein kinase Cε (Das et al., 2009), and these
possibilities have not been tested.
To test whether ethanol is acting upstream or downstream of the 5-HT2C receptor to induce
GABA release in the VTA, an illuminating experiment would be to block synthesis of 5-HT
with parachlorophenylalanine (PCPA) and determine if ethanol can still increase GABA
release. Because activation of the 5-HT2C receptor is required for ethanol to increase GABA
release in the VTA (Theile et al., 2009), a lack of effect of ethanol in the presence of PCPA
would indicate that endogenous 5-HT is essential for this ethanol action. If PCPA blocks
ethanol-enhanced GABA release, administration of a 5-HT2C agonist (Ro-60-0175) to the
slice in the absence of ethanol in the 5-HT-depleted tissue would be expected to increase
GABA release. If ethanol does not induce a further increase in GABA release in the
presence of the 5-HT2C agonist, this outcome would suggest that ethanol influences levels of
serotonin to increase GABA release. On the other hand, if ethanol induces a further increase
in GABA release in the presence of both PCPA and the 5-HT2C receptor agonist, this
outcome would suggest that ethanol can act downstream of the GPCR. Described next is
evidence that downstream GPCR-linked second messenger pathways are also involved in
the ability of ethanol to increase GABA release.
4. Evidence that GPCR-linked intracellular messengers influence ethanol-
enhanced GABA release
Activation of Gαs-, Gαq-, and Gαi-coupled GPCRs affects signaling through different
intracellular messenger pathways (see Fig. 2). Both the Gαi and Gαs subunits modulate
adenylate cyclase with Gαs stimulating adenylate cyclase and Gαi inhibiting it. When
adenylate cyclase is activated, it converts adenosine-5′-triphosphate (ATP) into 3′-5′-cyclic
adenosine monophosphate (cAMP), which can bind to protein kinase A (PKA) regulatory
subunits (Hanoune and Defer, 2001). The binding of cAMP to PKA frees the PKA catalytic
subunits from the regulatory subunits, allowing the catalytic subunits to phosphorylate
nearby targets. The Gαq subunit activates phospholipase C (PLC), which catalyzes the
conversion of phosphoinositol 4,5-bisphosphate into diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (IP3;Kiselyov et al., 2003). The released calcium from activation of the
IP3R and the presence of DAG both activate conventional protein kinase C (PKC) isoforms
(α, βI, βII, γ). Given the involvement of GPCRs in ethanol-enhanced GABA release, it seems
logical that the intracellular messengers linked to the GPCRs would influence the ethanol-
induced increase in GABA release.
In the presence of adenylate cyclase antagonists (dideoxya-denosine and SQ 22,536) or PKA
antagonists (H-89 and Rp-cAMP), ethanol was not able to significantly increase GABA
release at the interneuron-Purkinje cell synapse (Hirono et al., 2009; Kelm et al., 2008).
Additionally, a PLC antagonist (edelfosine) and two general PKC antagonists (chelerythrine
and calphostin C) significantly blocked ethanol from increasing spontaneous GABA release
at the interneuron-Purkinje cell synapse (Kelm et al., 2010). Studies with a PKCε antagonist
and PKCε null mice found that PKCε is required for ethanol to increase GABA release in
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the CeA (Bajo et al., 2008). Importantly, Bajo et al. (2008) also found that PKCε is required
for CRF to increase GABA release through activation of the CRF1 receptor, but it is
unknown if PKCε is facilitating activation of the CRF1 receptor or if activation of the CRF1
receptor leads to activation of PKCε. Overall, these results suggest that the Gαq- and Gαs-
coupled GPCR pathways play a critical role in the ability of ethanol to increase GABA
release.
While the Gαq-coupled (i.e. PLC/PKC) and Gαs-coupled (i.e. adenylate cyclase/PKA)
pathways are both necessary for ethanol to increase spontaneous GABA release at the
interneu-ron-Purkinje cell synapse, it is unknown if ethanol activates each pathway
separately or if there is cross-talk occurring between the pathways. Cross-talk occurs
between PKA and PKC at the GABAergic nucleus basalis of Meynert synapse (Kubota et
al., 2003), and there are effects of ethanol that involve cross-talk between these protein
kinases. For example, ethanol increases adenylate cyclase isoform 7 activity through a
PKCδ-mediated mechanism, which leads to activation of PKA (Tabakoff et al., 2001).
Ethanol also induces PKCε translocation to the cytosol through a PKA-dependent
mechanism (Yao et al., 2008); specifically, this translocation of PKCε is thought to involve
PKA activation of PLCβ. If ethanol is activating the pathways separately, there could be no
convergence of the pathways, and PKA and PKC could act directly at the release machinery
(Boczan et al., 2004; Lou et al., 2008). However, the pathways could converge at the
internal calcium stores (see Fig. 2) because phosphorylation of the IP3R and ryanodine
receptor (RyR) by PKA and PKC increases the amount of calcium release from the internal
stores (Bardo et al., 2006; Bugrim, 1999; Mignery et al., 1990; Patterson et al., 2004; Sobie
et al., 2006). As discussed below, calcium release from internal stores plays an important
role in ethanol-enhanced GABA release.
5. The role of calcium in ethanol-enhanced GABA release
It is well established that changes in presynaptic intracellular calcium levels can alter
spontaneous and evoked GABA release (Bardo et al., 2002, 2006; Glitsch, 2008; Yamasaki
et al., 2006). Incubating a cerebellar slice with a calcium chelator blocks the ability of
ethanol to increase GABA release at the interneuron-Purkinje cell synapse (Kelm et al.,
2010). Because limiting exposure of a membrane impermeable calcium chelator to the
postsynaptic neuron had no effect on this ethanol mechanism (Kelm et al., 2007), these
results suggest that a presynaptic, calcium-dependent mechanism is mediating ethanol-
enhanced GABA release at this synapse. To investigate the role of extracellular calcium in
this ethanol mechanism, a mechanically dissociated neuron preparation was used instead of
a slice to allow for instantaneous access of the calcium-free extracellular solution to the
synapse. This approach reduces the likelihood of simultaneously decreasing both
intracellular and extracellular calcium levels. Ethanol was still able to increase spontaneous
GABA release at the mechanically dissociated Purkinje cell synapse in a calcium-free
extracellular solution or in the presence of a voltage-dependent calcium channel inhibitor
(Kelm et al., 2007). These results demonstrate that, while calcium signaling does play a role
in this ethanol mechanism, this calcium is not coming from an extracellular source, a finding
which suggests that this calcium signaling is occurring intracellularly.
One potential source of intracellular calcium is the internal calcium store, which allows for
increases in calcium release through activation of IP3Rs and RyRs. Therefore, it is likely
that IP3Rs play a central role in ethanol-enhanced GABA release because an IP3R antagonist
blocks ethanol-enhanced GABA release in the cerebellum (Kelm et al., 2007) and VTA
(Theile et al., 2009). Similarly, blocking calcium release from the RyRs also inhibits
ethanol-enhanced GABA release (Kelm et al., 2007). After the internal stores are depleted of
calcium, a sarco (endo)plasmic reticulum Ca2+ ATPase (SERCA) pump senses this
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depletion and replenishes the stores (Kiselyov et al., 2003). After using a SERCA pump
antagonist in a protocol that depletes the internal stores of calcium, the ability of ethanol to
increase GABA release is blocked in the cerebellum (Kelm et al., 2007) and VTA (Theile et
al., 2009). Theile et al. (2009) also found that the ability of a 5-HT2C receptor agonist to
increase GABA release in the VTA is blocked by a SERCA pump antagonist. This finding is
consistent with 5-HT2C receptors activating a Gαq-protein that results in a subsequent
release of calcium through activation of the IP3Rs (Kiselyov et al., 2003), a process which
supports the internal calcium stores being necessary for a 5-HT2C receptor agonist to
increase release of GABA. As noted earlier, the ability of ethanol to increase GABA release
in the VTA is dependent on activation of the 5-HT2C receptor (Theile et al., 2009). Overall,
these data suggest that calcium release from internal stores plays an important role in
ethanol-enhanced GABA release.
6. The brain region-specificity of ethanol-enhanced GABA release
As noted above, while ethanol enhances GABA release in several brain regions, it is
ineffective at increasing GABA release in the cortex, lateral septum and thalamus (Criswell
et al., 2008; Jia et al., 2008). However, the mechanism mediating this brain region-
specificity is unknown. One explanation for the lack of ethanol effect could be the absence
of the relevant GPCRs at these presynaptic terminals. If ethanol acts upstream of the GPCRs
to release ligand, ethanol may not be able to increase the ligand concentration near the
appropriate GPCRs. Further, other factors could act indirectly to decrease the affinity or
constitutive activity of the GPCR. Alternatively, if both a Gαi- and Gαs-coupled GPCR are
activated by ethanol on the same terminal, the effect of one GPCR could negate the effect of
the other GPCR, leading to an overall lack of effect of ethanol on GABA release.
The regional specificity of ethanol-enhanced GABA release could also be mediated
downstream from the GPCRs, with a likely source being the internal calcium stores.
Blockade of RyRs or IP3Rs or depletion of internal calcium stores prevents ethanol-
enhanced GABA release while leaving a large portion of spontaneous GABA release intact
(Kelm et al., 2007; Theile et al., 2009). Thus, ethanol appears selective for the subtype of
GABA release that is dependent on calcium release from internal stores. If the proportion of
GABA release dependent upon internal calcium stores differs between brain regions, as has
been suggested (Yamasaki et al., 2006), brain regions with a low dependence on internal
stores would be less sensitive to the effect of ethanol on GABA release than regions with a
high dependence. Finally, the regional differences could be due to a differential function of
one or more of the multiple intracellular messenger pathways involved in ethanol-enhanced
GABA release.
Therefore, much work is needed to understand this regionally specific effect of ethanol on
GABA release. While it is possible that this lack of ethanol effect on GABA release in
certain brain regions could be due to an artifact introduced by the techniques used to prepare
the tissue or record from the neurons, this possibility seems unlikely because Criswell et al.
(2008) used the same preparation to show that ethanol increases GABA release in one brain
region while having no effect in another. Defining the basis of this regional specificity of
ethanol should be a priority because this new information will likely facilitate a broader
understanding of the means by which ethanol alters brain function via GABAergic
mechanisms.
7. Functional relevance of ethanol-enhanced GABA release
While there is clear evidence that ethanol increases GABA release, the behavioral and
functional relevance of this ethanol-induced increase in GABA release is less clear. To date,
all of the manipulations that influence the ability of ethanol to release GABA have other
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effects that are independent from ethanol-enhanced GABA release; therefore, we cannot
directly link any behavioral consequences to ethanol-induced GABA release. For example, a
CRF1 receptor antagonist prevents ethanol-enhanced GABA release in the CeA (Nie et al.,
2004) and also blocks the increased anxiety associated with repeated ethanol withdrawals
(Huang et al., 2010; Overstreet et al., 2004; Wills et al., 2009). While the correlation
between the prevention of ethanol-enhanced GABA release and the decrease in withdrawal-
induced anxiety is solid, the causal link is unclear. Furthermore, ethanol concentrations
below 20 mM have been ineffective at enhancing GABA release (Zhu and Lovinger, 2006).
A 20 mM ethanol concentration is equivalent to a blood ethanol level of almost 0.1%, which
is a concentration that is seldom reached by social drinkers, suggesting that many of the
effects of mild intoxication are not mediated by ethanol increasing GABA release.
Because binge drinkers often exceed a 20-mM ethanol concentration, one possibility is that
this deleterious drinking pattern selectively initiates ethanol-induced GABA release to
contribute to the long-term consequences of alcohol abuse. Further, chronic ethanol intake
does not appear to result in tolerance to the effect of ethanol on GABA release (Roberto et
al., 2004, 2006). Thus, the increased ethanol intake required to produce the same inebriating
effect in a tolerant individual would result in an increase in any deleterious effects
associated with the elevated release of GABA. In ethanol-dependent rats who are in
withdrawal, there is an increase in GABA dialysate and mIPSC frequency in the CeA
(Roberto et al., 2004), and administration of a CRF1 receptor antagonist blocks this increase
in GABA release (Roberto et al., 2010). This study suggests that there is a homeostatic
effect of GABA release during withdrawal from chronic ethanol, and that the relationship
between acute ethanol exposure and the GPCRs in the mechanism of ethanol-enhanced
GABA release could extend to chronic ethanol. Therefore, while more work is needed to
determine the behavioral relevance of ethanol-enhanced GABA release, future efforts should
focus on the role of chronic ethanol in ethanol-enhanced GABA release.
If future pharmacotherapy options for alcohol use disorders are based upon a change in
GABA release, the strategy will likely involve modulation of a GPCR, as do approximately
30% of all marketed prescription drugs (Hopkins and Groom, 2002). Naltrexone, which is
one of the drugs approved for the treatment of alcohol dependence, acts at a GPCR.
Naltrexone reduces alcohol intake and craving by blocking the rewarding effects of alcohol
(Volpicelli et al., 1995), and there is evidence that this mechanism involves modulation of
GABA release. Specifically, naltrexone reverses the ethanol-induced increase in dopamine
signaling in the mesolimbic pathway, suggesting that opioids are a mediator in the ethanol–
dopamine interaction (Benjamin et al., 1993). Importantly, opioids do not to affect VTA
dopamine neurons directly but instead hyperpolarize GABAergic interneurons (i.e.
disinhibition) that provide inhibitory signals to the VTA dopamine neurons (Johnson and
North, 1992). Overall, these data suggest that increasing the amount of GABA released onto
the VTA dopamine neurons can reduce the rewarding properties associated with dopamine
signaling in the mesolimbic pathway.
In addition to naltrexone, there are other drugs targeting GPCRs that have the potential to be
new treatment options. In alcohol-dependent individuals, prazosin, an antagonist at the Gαq-
linked α1 adrenergic receptor, reduces the number of drinking days (Simpson et al., 2009).
Likewise, LY686017, an antagonist at the Gαq-linked neurokinin 1 receptor, reduces alcohol
craving in alcohol-dependent individuals (George et al., 2008). Baclofen, a GABAB receptor
agonist, promotes abstinence, prevents relapse, and reduces withdrawal in individuals with
an alcohol use disorder (Addolorato et al., 2002, 2007), but these results have not always
been reproducible (Garbutt et al., 2007). Baclofen can be taken by alcohol-dependent
individuals who also have cirrhosis of the liver, which is a population without many
treatment options due to extensive liver metabolism of most drugs (Addolorato et al., 2007).
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Overall, these data demonstrate that pharmacological manipulation of GPCR signaling is a
promising strategy for treating alcohol use disorders, and different GPCR agonists and
antagonists should continue to be pursued as treatment options, especially the drugs that
target the GPCRs that affect GABA release. While the intracellular messengers located
downstream from the GPCRs could possibly be targeted in certain circumstances, the
promiscuity of these second messengers will likely limit their use.
8. Summary
In addition to any postsynaptic actions, evidence is provided that ethanol increases GABA
release in multiple brain regions. The ability of ethanol to increase GABA release can be
influenced by GPCRs and the intracellular messengers located downstream from the
GPCRs. In the CeA and the VTA, activation of a GPCR is required for ethanol to increase
GABA release; therefore, future work should focus on determining if activation of other
GPCRs is required for ethanol to increase GABA release in other brain regions. The way in
which ethanol interacts with the GPCR to increase GABA release is uncertain, but it likely
does not involve ethanol binding directly to the GPCR. Ethanol does not increase GABA
release in every brain region, and this circumstance could potentially be explained by
whether or not there is activation of a GPCR pathway at a GABAergic synapse or if the
GABA released at a synapse is dependent on calcium release from internal stores. Overall,
significant progress has been made in exploring the mechanism of ethanol-enhanced GABA
release, and it has been clearly established that GPCRs play an important role in this ethanol
mechanism and in the treatment of alcohol use disorders. To expand upon the potential
relevance of this ethanol effect on GABA release to alcohol dependence, future work should
focus on whether chronic ethanol exposure influences ethanol-enhanced GABA release and
if GPCRs contribute to any of the observed differences.
Abbreviations
cAMP 3′-5′-cyclic adenosine monophosphate
5-HT2C 5-hydroxytryptamine 2C
ATP adenosine-5′-triphosphate
baf A1 bafilomycin A1
CB1 cannabinoid-1
CeA central nucleus of the amygdala
CRF corticotropin-releasing factor
DAG diacylglycerol
eIPSC evoked inhibitory postsynaptic current
GABA gamma-aminobutyric acid
GPCRs G protein-coupled receptors
IP3 inositol 1,4,5-trisphosphate
mIPSC miniature inhibitory postsynaptic current
PPR paired pulse ratio
PCPA parachlorophenylalanine
PLC phospholipase C
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PKA protein kinase A
PKC protein kinase C
RyR ryanodine receptor
SERCA sarco(endo)plasmic reticulum Ca2+ ATPase
sIPSC spontaneous inhibitory postsynaptic current
VTA ventral tegmental area
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Ethanol increases vesicular release of GABA. A: A trace from a representative neuron
illustrating the effect of ethanol (100mM) on mIPSC frequency. B: Ethanol significantly
increased mIPSC frequency compared to control and washout [*p<.05; repeated measures
ANOVA; F(2,42)=18.3]. The mIPSC frequency values for the control and washout groups
were not significantly different. C: Incubating the slice with bafilomycin A1 (baf A1), which
eliminates the pH and electrical gradients necessary for GABA transporters to fill the
vesicles (Maycox et al., 1990), greatly reduced mIPSC frequency. In the presence of
bafilomycin A1, 100 mM ethanol did not significantly increase mIPSC frequency compared
to control. D: Ethanol (100 mM) significantly increased mIPSC frequency (see B) in
contrast to weak and non-significant effects on mIPSC fast decay time (τ-fast), slow decay
time (τ-slow) and amplitude. Overall, these results support that the ethanol-induced increase
in mIPSC frequency should be interpreted as an increase in spontaneous GABA release from
the presynaptic terminal. This figure was reproduced from Kelm et al. (2010).
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Ethanol, GABAergic neurotransmission, and GPCRs. Ethanol has been shown to act directly
at the postsynaptic GABAA receptor, but ethanol can also increase the amount of GABA
released from the presynaptic terminal. While the mechanism mediating this ethanol effect is
not fully understood, evidence suggests that the GPCRs and their respective pathways are
involved. It is unlikely that ethanol is binding directly to the GPCR and instead could be
acting upstream of the receptor by increasing the amount of ligand reaching the receptor or
changing the receptor properties. Ethanol could also interact directly with one of the
intracellular messengers (see the text for a detailed description of the GPCR pathways).
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Table 1
A summary of the slice electrophysiological techniques used in each brain region to measure the effect of
ethanol on GABA release.




Basolateral amygdala (MDN) mIPSCs Increased mIPSC frequency Zhu and Lovinger (2006)
Basolateral amygdala (MDN) sIPSCs Increased sIPSC frequency Zhu and Lovinger (2006)
Basolateral amygdala PPR Decreased PPR Silberman et al. (2008)
Brainstem motor mIPSC Increased mIPSC frequency Sebe et al. (2003)
Central nucleus of the amygdala mIPSC Increased mIPSC frequency Roberto et al. (2003), Kang-Park et al.
(2007), Nie et al. (2009)
Central nucleus of the amygdala PPR Decreased PPR Roberto et al. (2003), Nie et al. (2004)
Cerebellar Purkinje (MDN and slice) mIPSCs Increased mIPSC frequency Ming et al. (2006), Kelm et al. (2007),
Mameli et al. (2008), Hirono et al. (2009)
Cerebellar Purkinje (MDN and slice) sIPSCs Increased sIPSC frequency Criswell et al. (2008), Mameli et al. (2008),
Hirono et al. (2009)
Cerebellar Purkinje PPR Decreased PPR Kelm et al. (2007), Criswell et al. (2008),
Mameli et al. (2008)
Cerebellar granule mIPSCs Increased mIPSC frequency Carta et al. (2004)
Cerebellar granule sIPSCs Increased sIPSC frequency Carta et al. (2004)
Cerebrocortical (MDN) sIPSCs No effect Criswell et al. (2008)
Hippocampal CA1 pyramidal mIPSCs Increased mIPSC frequency Li et al. (2006)
Hippocampal CA1 pyramidal sIPSCs Increased sIPSC frequency Ariwodola and Weiner (2004), Li et al.
(2006)
Lateral septal (MDN) sIPSCs No effect Criswell et al. (2008)
Lateral septal PPR No effect Criswell et al. (2008)
Spinal cord motor mIPSCs Increased mIPSC frequency Ziskind-Conhaim et al. (2003)
Spinal cord motor sIPSCs Increased sIPSC frequency Cheng et al. (1999)
Substantia nigra (MDN) mIPSCs Increased mIPSC frequency Criswell et al. (2008)
Thalamocortical relay sIPSCs No effect Jia et al. (2008)
VTA mIPSCs Increased mIPSC frequency1 and
no effect2
1: Theile et al. (2008), 2: Xiao and Ye
(2008)2
VTA sIPSCs Increased sIPSC frequency Theile et al. (2008), Xiao and Ye (2008)a
VTA PPR Decreased PPR Theile et al. (2008)
a
Note: The increase in sIPSC frequency was only seen in the presence of a μ-opioid receptor agonist. MDN: mechanically dissociated neurons.
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